The effects of balance training using the Homebalance instrument in people with multiple sclerosis

Home-based balance training using biofeedback with the Homebalance instrument in people with multiple sclerosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11744221

Enrollment

Registered

2018-08-07

Start date

2016-01-01

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis with balance difficulties Nervous System Diseases Multiple sclerosis with balance difficulties

Interventions

Participants in the intervention group received individually tailored home-based balance exercise training using Homebalance® for at least 15 minutes each day for 4 weeks. Participants were allowed to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old 2. Multiple sclerosis (clinically stable without relapse or worsening in the previous 3 months) 3. Able to walk with or without a walking aid for at least 20 m (EDSS 1-6.5) 4. Able to maintain a standing position for at least 10 minutes 5. Able to perform exercise

Exclusion criteria

Exclusion criteria: 1. Inpatient rehabilitation programme during the previous 3 months 2. Orthopaedic problems or other conditions affecting balance and gait performance 3. Blurred vision 4. Severe cognitive impairment or psychiatric disorders 5. Pregnancy 6. Weight over 150 kg 7. Receiving other physiotherapy targeting balance problems 8. Changes in lifestyle prior to or during the study

Design outcomes

Primary

Measure	Time frame
Balance was assessed at the baseline, after 4 weeks and at the 4 week follow-up (8 weeks after the start of the intervention) using the following: 1. Berg Balance Scale (BBS) 2. Mini-Balance Evaluation Systems Test (Mini-BEST)	—

Secondary

Measure	Time frame
The following were assessed at the baseline, after 4 weeks and at the 4 week follow-up (8 weeks after the start of the intervention): 1. Severity of multiple sclerosis, assessed using the Multiple Sclerosis Functional Composite (MSFC) 2. Gait parameters, assessed using the GAITRite instrument 3. Subjective perceived balance confidence, assessed using the following: 3.1. Activities-specific Balance Confidence Scale (ABC) 3.2. Falls Efficacy Scale (FESI) 4. Subject perceived gait difficulties, assessed using the 12-item MS Walking Scale (MSWS12)	—

Measure

Time frame

The following were assessed at the baseline, after 4 weeks and at the 4 week follow-up (8 weeks after the start of the intervention): 1. Severity of multiple sclerosis, assessed using the Multiple Sclerosis Functional Composite (MSFC) 2. Gait parameters, assessed using the GAITRite instrument 3. Subjective perceived balance confidence, assessed using the following: 3.1. Activities-specific Balance Confidence Scale (ABC) 3.2. Falls Efficacy Scale (FESI) 4. Subject perceived gait difficulties, assessed using the 12-item MS Walking Scale (MSWS12)

—

Countries

Czech Republic

Contacts

Public ContactKlara Novotna

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026